Go to Publication

Continue Reading Assessment of linezolid efficacy and safety in MDR- and XDR-TB: an Indian perspective.

Abstract The presence of a non-resolving pneumonia warrants the suspicion of a possible malignancy. While pulmonary involvement in Hodgkin's disease can present as a non-resolving pneumonia, the clinical…

Continue Reading A 12-year-old girl with Hodgkin’s disease presenting as a non-resolving pneumonia and an endobronchial nodule.

Abstract BACKGROUND: Extended-duration low-molecular-weight heparin has been shown to prevent venous thromboembolism (VTE) in high-risk surgical patients. OBJECTIVE: To evaluate the efficacy and safety of extended-duration enoxaparin thromboprophylaxis…

Continue Reading Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial.

Abstract Oxaliplatin has been approved for use as an adjuvant treatment in stage III colorectal carcinoma by the US-FDA. The majority of toxicity caused by this drug is…

Continue Reading Oxaliplatin-induced lung fibrosis.

Abstract Pulmonary alveolar proteinosis (PAP) is a rare disorder characterized by accumulation of amorphous acellular phospholipid material in the lungs. Whole lung lavage is the standard therapy which…

Continue Reading Pulmonary alveolar proteinosis with respiratory failure-anaesthetic management of whole lung lavage.

Abstract The link between tuberculosis (TB) and diabetes mellitus (DM) has occupied the center stage of discussion. Experts have raised concern about the merging epidemics of tuberculosis and…

Continue Reading Tuberculosis and diabetes mellitus: merging epidemics.

Abstract SETTING: Tertiary referral centre, private hospital, Mumbai, India. OBJECTIVE: To analyse the incidence of fluoroquinolone (FQ) resistant Mycobacterium tuberculosis (TB) in our laboratory from 1995 to 2004.…

Continue Reading Increasing incidence of fluoroquinolone-resistant Mycobacterium tuberculosis in Mumbai, India.